PL2622078T3 - Białko fuzyjne dla ekspresji białka wydzielniczego - Google Patents
Białko fuzyjne dla ekspresji białka wydzielniczegoInfo
- Publication number
- PL2622078T3 PL2622078T3 PL11763647T PL11763647T PL2622078T3 PL 2622078 T3 PL2622078 T3 PL 2622078T3 PL 11763647 T PL11763647 T PL 11763647T PL 11763647 T PL11763647 T PL 11763647T PL 2622078 T3 PL2622078 T3 PL 2622078T3
- Authority
- PL
- Poland
- Prior art keywords
- protein
- secretory
- expression
- fusion protein
- fusion
- Prior art date
Links
- 102000040739 Secretory proteins Human genes 0.000 title 1
- 108091058545 Secretory proteins Proteins 0.000 title 1
- 108020001507 fusion proteins Proteins 0.000 title 1
- 102000037865 fusion proteins Human genes 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/96—Stabilising an enzyme by forming an adduct or a composition; Forming enzyme conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- C07K14/245—Escherichia (G)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
- C12N15/625—DNA sequences coding for fusion proteins containing a sequence coding for a signal sequence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Mycology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE1051000 | 2010-09-28 | ||
| PCT/EP2011/066854 WO2012041899A1 (en) | 2010-09-28 | 2011-09-28 | Fusion protein for secretory protein expression |
| EP11763647.2A EP2622078B1 (en) | 2010-09-28 | 2011-09-28 | Fusion protein for secretory protein expression |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2622078T3 true PL2622078T3 (pl) | 2015-05-29 |
Family
ID=44719941
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL11763647T PL2622078T3 (pl) | 2010-09-28 | 2011-09-28 | Białko fuzyjne dla ekspresji białka wydzielniczego |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US9322011B2 (pl) |
| EP (1) | EP2622078B1 (pl) |
| CN (1) | CN103228787B (pl) |
| CA (1) | CA2811699C (pl) |
| ES (1) | ES2529442T3 (pl) |
| PL (1) | PL2622078T3 (pl) |
| WO (1) | WO2012041899A1 (pl) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201009861D0 (en) * | 2010-06-11 | 2010-07-21 | Novartis Ag | OMV vaccines |
| EP2833911A4 (en) | 2012-04-06 | 2016-07-13 | Univ Cornell | SUB-VACCINE VACCINATING PLATFORM FOR ROBUST HUMORAL AND CELLULAR IMMUNE RESPONSES |
| US10357555B2 (en) * | 2012-07-10 | 2019-07-23 | Transgene Sa | Mycobacterial antigen vaccine |
| US10676723B2 (en) | 2015-05-11 | 2020-06-09 | David Gordon Bermudes | Chimeric protein toxins for expression by therapeutic bacteria |
| BR112017025954A2 (pt) * | 2015-06-02 | 2018-08-14 | De Staat Der Nederlanden, Vert. Door De Minister Van Vws, Ministerie Van Volksgezondheid, Welzijn En Sport | apresentação em superfície de antígenos em vesículas de membrana externa gram-negativa |
| EP4524157A3 (en) | 2017-10-25 | 2025-06-18 | Abera Bioscience AB | Omv display |
| GB202009411D0 (en) * | 2020-06-19 | 2020-08-05 | Prokarium Ltd | Autotransporter systems |
| EP3981879A1 (en) * | 2020-10-09 | 2022-04-13 | Stada Arzneimittel Ag | Method of producing a recombinant protein in a host cell which has a disabled rhamnose metabolism as well as expression vectors, host cells and recombinant proteins thereof |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7129060B1 (en) * | 1996-03-15 | 2006-10-31 | Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V | Export systems for recombinant proteins |
| ATE346168T1 (de) | 2001-03-02 | 2006-12-15 | Univ Des Saarlandes Wissens Un | Funktionelles oberflächendisplay von polypeptiden |
| GB0220199D0 (en) * | 2002-08-30 | 2002-10-09 | Univ Utrecht | Mutant protein and refolding method |
| DK2255826T3 (en) * | 2002-08-02 | 2016-06-20 | Glaxosmithkline Biologicals Sa | Neisserial vaccine compositions comprising a combination of antigens. |
| AU2003901316A0 (en) * | 2003-03-21 | 2003-04-03 | The Royal Alexandra Hospital For Children | Regulation of cell surface proteins |
| DE602004028262D1 (de) * | 2003-10-02 | 2010-09-02 | Glaxosmithkline Biolog Sa | B. pertussis antigene und ihre verwendung bei der vakzinierung |
| US7628995B2 (en) * | 2003-12-23 | 2009-12-08 | Glaxosmithkline Biologicals S.A. | Outer membrane vesicles and uses thereof |
| ES2301262B1 (es) * | 2004-01-14 | 2009-05-29 | Consejo Sup. Investig. Cientificas | Generacion de adhesion especifica en bacterias gram negativas mediante el anclaje de monodominos de inmunoglobulinas en su superficie con autotransportadores. |
| US8029777B2 (en) * | 2004-08-13 | 2011-10-04 | Marshall Barry J | Helicobacter system and uses thereof |
| US9259463B2 (en) * | 2006-01-16 | 2016-02-16 | The United States Of America, As Represented By The Secretary, Department Of Health & Human Services | Chlamydia vaccine |
| US8293685B2 (en) * | 2007-07-26 | 2012-10-23 | The Regents Of The University Of California | Methods for enhancing bacterial cell display of proteins and peptides |
| US9482663B2 (en) * | 2009-09-09 | 2016-11-01 | Autodisplay Biotech Gmbh | Method for binding a recombinant polypeptide to a carrier |
| US8771669B1 (en) * | 2010-02-09 | 2014-07-08 | David Gordon Bermudes | Immunization and/or treatment of parasites and infectious agents by live bacteria |
| ES2663872T3 (es) * | 2010-03-11 | 2018-04-17 | Glaxosmithkline Biologicals S.A. | Composición inmunogénica o vacuna contra infección o enfermedad bacteriana gramnegativa, por ejemplo, por Neisseria |
| EP2619306B1 (en) * | 2010-09-23 | 2015-05-20 | Autodisplay Biotech GmbH | Surface display of polypeptides containing a metal porphyrin or a flavin |
-
2011
- 2011-09-28 CN CN201180046204.3A patent/CN103228787B/zh active Active
- 2011-09-28 EP EP11763647.2A patent/EP2622078B1/en active Active
- 2011-09-28 US US13/876,425 patent/US9322011B2/en active Active
- 2011-09-28 PL PL11763647T patent/PL2622078T3/pl unknown
- 2011-09-28 WO PCT/EP2011/066854 patent/WO2012041899A1/en not_active Ceased
- 2011-09-28 ES ES11763647.2T patent/ES2529442T3/es active Active
- 2011-09-28 CA CA2811699A patent/CA2811699C/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| HK1187369A1 (en) | 2014-04-04 |
| EP2622078B1 (en) | 2014-11-05 |
| CN103228787B (zh) | 2017-06-23 |
| WO2012041899A1 (en) | 2012-04-05 |
| CA2811699C (en) | 2019-07-02 |
| US20130344099A1 (en) | 2013-12-26 |
| EP2622078A1 (en) | 2013-08-07 |
| CN103228787A (zh) | 2013-07-31 |
| CA2811699A1 (en) | 2012-04-05 |
| US9322011B2 (en) | 2016-04-26 |
| ES2529442T3 (es) | 2015-02-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL232743A0 (en) | anticancer fusion protein | |
| EP2729488A4 (en) | PROCESS FOR PREPARING MULTIMANT POLYPEPTIDES | |
| ZA201300677B (en) | Anticancer fusion protein | |
| LT3321287T (lt) | Sulieti baltymai ir sudėtinės vakcinos | |
| SG10202100341XA (en) | Npp1 fusion proteins | |
| EP2772230A4 (en) | FUSION GRAFT | |
| ZA201303449B (en) | Anticancer fusion protein | |
| LT2661496T (lt) | Priešvėžinis sulietas baltymas | |
| ZA201405460B (en) | Anticancer fusion protein | |
| EP2698386B8 (en) | Fusion protein | |
| PL2622078T3 (pl) | Białko fuzyjne dla ekspresji białka wydzielniczego | |
| EP2657337A4 (en) | FUSION PROTEIN | |
| ZA201308597B (en) | Anticancer fusion protein | |
| ZA201207425B (en) | Fusion protein | |
| GB201007955D0 (en) | Somatosatin fusion proteins | |
| GB201107189D0 (en) | Fusion proteins | |
| GB201114701D0 (en) | Fusion proteins | |
| AU2011905145A0 (en) | Fusion Protein | |
| GB201104152D0 (en) | Fusion Polypeptide | |
| GB201004150D0 (en) | Modified receptor fusion proteins | |
| GB201007550D0 (en) | Modified receptor fusion proteins | |
| GB201010202D0 (en) | Fusion polypeptides | |
| HUP1100282A2 (en) | Protein factor | |
| PL393146A1 (pl) | Przeciwnowotworowe białko fuzyjne | |
| GB201103169D0 (en) | Protein expression |